HEADER LYASE 19-MAR-08 3CLM TITLE CRYSTAL STRUCTURE OF TRANSALDOLASE (YP_208650.1) FROM NEISSERIA TITLE 2 GONORRHOEAE FA 1090 AT 1.14 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSALDOLASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.2.1.2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NEISSERIA GONORRHOEAE; SOURCE 3 ORGANISM_TAXID: 242231; SOURCE 4 STRAIN: FA 1090; SOURCE 5 ATCC: 700825; SOURCE 6 GENE: YP_208650.1, TAL, NGO1610; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS YP_208650.1, TRANSALDOLASE, STRUCTURAL GENOMICS, JOINT CENTER FOR KEYWDS 2 STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, KEYWDS 3 TRANSFERASE, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 7 30-OCT-24 3CLM 1 REMARK REVDAT 6 01-FEB-23 3CLM 1 REMARK SEQADV REVDAT 5 24-JUL-19 3CLM 1 REMARK LINK REVDAT 4 25-OCT-17 3CLM 1 REMARK REVDAT 3 13-JUL-11 3CLM 1 VERSN REVDAT 2 24-FEB-09 3CLM 1 VERSN REVDAT 1 01-APR-08 3CLM 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF TRANSALDOLASE (YP_208650.1) FROM JRNL TITL 2 NEISSERIA GONORRHOEAE FA 1090 AT 1.14 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH AND HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.58 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 3 NUMBER OF REFLECTIONS : 107466 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.130 REMARK 3 R VALUE (WORKING SET) : 0.130 REMARK 3 FREE R VALUE : 0.161 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 5430 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MOEWS & KRETSINGER, J.MOL.BIOL. 91 (1975) REMARK 3 201-228 REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 6.17 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 10.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. ANISOTROPIC REFINEMENT REDUCED FREE R (NO CUTOFF) BY 3.2%. REMARK 3 2. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 4. 1,2-ETHANEDIOL MOLECULES, A SULFATE ION FROM THE REMARK 3 CRYSTALLIZATION CONDITIONS AND A CHLORIDE ION HAVE BEEN REMARK 3 MODELED IN THE SOLVENT STRUCTURE. REMARK 4 REMARK 4 3CLM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1000046924. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-NOV-07; 26-OCT-07 REMARK 200 TEMPERATURE (KELVIN) : 100; 100 REMARK 200 PH : 6.0; 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : SSRL; APS REMARK 200 BEAMLINE : BL11-1; 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97916; 0.97953, 0.91840, REMARK 200 0.97939 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL; SI(111) REMARK 200 DOUBLE CRYSTAL REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING); REMARK 200 ADJUSTABLE FOCUSING MIRRORS IN K- REMARK 200 B GEOMETRY REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD; MARMOSAIC REMARK 200 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 107548 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.140 REMARK 200 RESOLUTION RANGE LOW (A) : 29.579 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 44.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.32600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD, MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP, PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: TWO CRYSTALS WERE USED FOR THE SOLUTION OF THIS STRUCTURE. REMARK 200 1.74 ANGSTROM MAD DATA COLLECTED FROM A CRYSTAL IN SPACE GROUP REMARK 200 C2 (C 1 2 1) WERE USED TO PHASE AND TRACE AN INITIAL MODEL. THIS REMARK 200 MODEL WAS THEN USED FOR MOLECULAR REPLACEMENT AGAINST A CRYSTAL REMARK 200 IN SPACE GROUP P212121 THAT DIFFRACTED TO 1.14 ANGSTROMS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 0.20M (NH4)2SO4, 20.0% PEG REMARK 280 3350, NO BUFFER PH 6.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K. NANODROP, 0.16M CA(OAC)2, 20.0% GLYCEROL, 14.4% REMARK 280 PEG 8000, 0.1M CACODYLATE PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.07000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.89500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.51500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.89500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.07000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.51500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE CRYSTAL PACKING ANALYSIS SUPPORTED REMARK 300 BY ANALYTICAL SIZE EXCLUSION CHROMATOGRAPHY LEADS TO THE ASSIGNMENT REMARK 300 OF A MONOMER AS THE SIGNIFICANT OLIGOMERIC FORM IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 100 NZ REMARK 470 GLU A 309 CD OE1 OE2 REMARK 470 LYS A 345 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MSE A 1 CA - CB - CG ANGL. DEV. = 16.3 DEGREES REMARK 500 ARG A 21 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 GLU A 28 OE1 - CD - OE2 ANGL. DEV. = 7.5 DEGREES REMARK 500 MSE A 32 CA - CB - CG ANGL. DEV. = 11.2 DEGREES REMARK 500 ARG A 84 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 GLN A 117 CB - CG - CD ANGL. DEV. = 18.3 DEGREES REMARK 500 ALA A 144 O - C - N ANGL. DEV. = -12.3 DEGREES REMARK 500 GLY A 145 C - N - CA ANGL. DEV. = 18.7 DEGREES REMARK 500 ARG A 184 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 ARG A 216 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 216 NE - CZ - NH2 ANGL. DEV. = -7.3 DEGREES REMARK 500 ARG A 252 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 ASP A 308 CB - CG - OD1 ANGL. DEV. = 8.8 DEGREES REMARK 500 ARG A 313 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG A 330 NE - CZ - NH1 ANGL. DEV. = -3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 141 45.34 -80.55 REMARK 500 ILE A 202 -71.01 -109.56 REMARK 500 HIS A 296 25.79 -150.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 352 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 353 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 354 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 355 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 356 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 357 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 358 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 359 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 360 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 361 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 362 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 363 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 364 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 379639 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE FOLLOWED BY THE TARGET SEQUENCE. DBREF 3CLM A 1 351 UNP Q5F6E9 TAL_NEIG1 1 351 SEQADV 3CLM GLY A 0 UNP Q5F6E9 EXPRESSION TAG SEQRES 1 A 352 GLY MSE THR ILE LEU SER ASP VAL LYS ALA LEU GLY GLN SEQRES 2 A 352 GLN ILE TRP LEU ASP ASN LEU SER ARG SER LEU VAL GLN SEQRES 3 A 352 SER GLY GLU LEU ALA GLN MSE LEU LYS GLN GLY VAL CYS SEQRES 4 A 352 GLY VAL THR SER ASN PRO ALA ILE PHE GLN LYS ALA PHE SEQRES 5 A 352 ALA GLY ASP ALA LEU TYR ALA ASP GLU VAL ALA ALA LEU SEQRES 6 A 352 LYS ARG GLN ASN LEU SER PRO LYS GLN ARG TYR GLU THR SEQRES 7 A 352 MSE ALA VAL ALA ASP VAL ARG ALA ALA CYS ASP VAL CYS SEQRES 8 A 352 LEU ALA GLU HIS GLU SER THR GLY GLY LYS THR GLY PHE SEQRES 9 A 352 VAL SER LEU GLU VAL SER PRO GLU LEU ALA LYS ASP ALA SEQRES 10 A 352 GLN GLY THR VAL GLU GLU ALA ARG ARG LEU HIS ALA ALA SEQRES 11 A 352 ILE ALA ARG LYS ASN ALA MSE ILE LYS VAL PRO ALA THR SEQRES 12 A 352 ASP ALA GLY ILE ASP ALA LEU GLU THR LEU VAL SER ASP SEQRES 13 A 352 GLY ILE SER VAL ASN LEU THR LEU LEU PHE SER ARG ALA SEQRES 14 A 352 GLN THR LEU LYS ALA TYR ALA ALA TYR ALA ARG GLY ILE SEQRES 15 A 352 ALA LYS ARG LEU ALA ALA GLY GLN SER VAL ALA HIS ILE SEQRES 16 A 352 GLN VAL VAL ALA SER PHE PHE ILE SER ARG VAL ASP SER SEQRES 17 A 352 ALA LEU ASP ALA THR LEU PRO ASP ARG LEU LYS GLY LYS SEQRES 18 A 352 THR ALA ILE ALA LEU ALA LYS ALA ALA TYR GLN ASP TRP SEQRES 19 A 352 GLU GLN TYR PHE THR ALA PRO GLU PHE ALA ALA LEU GLU SEQRES 20 A 352 ALA GLN GLY ALA ASN ARG VAL GLN LEU LEU TRP ALA SER SEQRES 21 A 352 THR GLY VAL LYS ASN PRO ALA TYR PRO ASP THR LEU TYR SEQRES 22 A 352 VAL ASP SER LEU ILE GLY VAL HIS THR VAL ASN THR VAL SEQRES 23 A 352 PRO ASP ALA THR LEU LYS ALA PHE ILE ASP HIS GLY THR SEQRES 24 A 352 ALA LYS ALA THR LEU THR GLU SER ALA ASP GLU ALA ARG SEQRES 25 A 352 ALA ARG LEU ALA GLU ILE ALA ALA LEU GLY ILE ASP VAL SEQRES 26 A 352 GLU THR LEU ALA ALA ARG LEU GLN GLU ASP GLY LEU LYS SEQRES 27 A 352 GLN PHE GLU GLU ALA PHE GLU LYS LEU LEU ALA PRO LEU SEQRES 28 A 352 VAL MODRES 3CLM MSE A 1 MET SELENOMETHIONINE MODRES 3CLM MSE A 32 MET SELENOMETHIONINE MODRES 3CLM MSE A 78 MET SELENOMETHIONINE MODRES 3CLM MSE A 136 MET SELENOMETHIONINE HET MSE A 1 18 HET MSE A 32 13 HET MSE A 78 13 HET MSE A 136 8 HET CL A 352 1 HET SO4 A 353 5 HET EDO A 354 8 HET EDO A 355 4 HET EDO A 356 4 HET EDO A 357 4 HET EDO A 358 4 HET EDO A 359 4 HET EDO A 360 4 HET EDO A 361 4 HET EDO A 362 4 HET EDO A 363 4 HET EDO A 364 4 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 4(C5 H11 N O2 SE) FORMUL 2 CL CL 1- FORMUL 3 SO4 O4 S 2- FORMUL 4 EDO 11(C2 H6 O2) FORMUL 15 HOH *437(H2 O) HELIX 1 1 THR A 2 LEU A 10 1 9 HELIX 2 2 SER A 20 SER A 26 1 7 HELIX 3 3 GLY A 27 LYS A 34 1 8 HELIX 4 4 ASN A 43 ASP A 54 1 12 HELIX 5 5 LEU A 56 LYS A 65 1 10 HELIX 6 6 SER A 70 THR A 97 1 28 HELIX 7 7 SER A 109 ALA A 113 5 5 HELIX 8 8 ASP A 115 ALA A 131 1 17 HELIX 9 9 THR A 142 ASP A 155 1 14 HELIX 10 10 SER A 166 ALA A 187 1 22 HELIX 11 11 ILE A 202 ASP A 210 1 9 HELIX 12 12 ALA A 211 LEU A 213 5 3 HELIX 13 13 PRO A 214 LYS A 218 5 5 HELIX 14 14 LYS A 220 ALA A 239 1 20 HELIX 15 15 ALA A 239 ALA A 247 1 9 HELIX 16 16 THR A 270 LEU A 276 1 7 HELIX 17 17 PRO A 286 GLY A 297 1 12 HELIX 18 18 SER A 306 LEU A 320 1 15 HELIX 19 19 ASP A 323 ALA A 348 1 26 HELIX 20 20 PRO A 349 VAL A 351 5 3 SHEET 1 A 9 GLN A 12 LEU A 16 0 SHEET 2 A 9 VAL A 40 THR A 41 1 O THR A 41 N LEU A 16 SHEET 3 A 9 VAL A 104 GLU A 107 1 O SER A 105 N VAL A 40 SHEET 4 A 9 ALA A 135 PRO A 140 1 O LYS A 138 N LEU A 106 SHEET 5 A 9 VAL A 159 LEU A 164 1 O ASN A 160 N ILE A 137 SHEET 6 A 9 VAL A 196 PHE A 201 1 O SER A 199 N LEU A 161 SHEET 7 A 9 GLN A 254 ALA A 258 1 O LEU A 256 N ALA A 198 SHEET 8 A 9 THR A 281 VAL A 285 1 O VAL A 282 N TRP A 257 SHEET 9 A 9 GLN A 12 LEU A 16 1 N TRP A 15 O VAL A 285 LINK C GLY A 0 N MSE A 1 1555 1555 1.33 LINK C MSE A 1 N THR A 2 1555 1555 1.33 LINK C GLN A 31 N MSE A 32 1555 1555 1.33 LINK C MSE A 32 N LEU A 33 1555 1555 1.33 LINK C THR A 77 N MSE A 78 1555 1555 1.33 LINK C MSE A 78 N ALA A 79 1555 1555 1.33 LINK C ALA A 135 N MSE A 136 1555 1555 1.33 LINK C MSE A 136 N ILE A 137 1555 1555 1.31 SITE 1 AC1 5 ASN A 43 LYS A 138 THR A 162 PHE A 201 SITE 2 AC1 5 HOH A 465 SITE 1 AC2 7 SER A 203 ARG A 204 SER A 259 LYS A 263 SITE 2 AC2 7 HOH A 426 HOH A 569 HOH A 767 SITE 1 AC3 8 ASP A 17 ASN A 43 PHE A 201 ARG A 204 SITE 2 AC3 8 ALA A 258 SER A 259 HOH A 465 HOH A 553 SITE 1 AC4 7 GLU A 95 GLY A 99 LYS A 133 HIS A 193 SITE 2 AC4 7 HOH A 421 HOH A 633 HOH A 773 SITE 1 AC5 6 LYS A 133 GLY A 156 SER A 158 HIS A 193 SITE 2 AC5 6 HOH A 490 HOH A 516 SITE 1 AC6 6 LYS A 218 LYS A 220 TYR A 267 LEU A 271 SITE 2 AC6 6 HOH A 444 HOH A 740 SITE 1 AC7 5 ALA A 9 GLY A 321 ILE A 322 ASP A 323 SITE 2 AC7 5 HOH A 588 SITE 1 AC8 6 PRO A 110 LEU A 336 GLU A 340 HOH A 505 SITE 2 AC8 6 HOH A 708 HOH A 714 SITE 1 AC9 4 GLN A 73 GLU A 76 THR A 77 HOH A 549 SITE 1 BC1 8 LYS A 8 GLU A 93 SER A 96 THR A 97 SITE 2 BC1 8 ARG A 330 ASP A 334 LYS A 337 HOH A 682 SITE 1 BC2 4 HIS A 127 ASP A 155 HOH A 683 HOH A 783 SITE 1 BC3 3 ASP A 147 ALA A 148 THR A 151 SITE 1 BC4 4 GLY A 11 HIS A 280 HOH A 435 HOH A 693 CRYST1 42.140 83.030 89.790 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023730 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012044 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011137 0.00000